SavedAdd your journal

Journals / Journal of Health Sciences and Medicine / 2026 / Volume: 9 Issue: 3

Effects of exercise-induced myokines on rehabilitation and metabolic regulation

Elif Zeynep Öztürk(Kütahya Sağlık Bilimleri Üniversitesi)0000-0002-8741-2766
Mehlika Alataş(BAHÇEŞEHİR ÜNİVERSİTESİ)0000-0002-7703-9312
Pages
—
Publication Date
2026-05-19
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review examines the effects of exercise-induced myokines on clinical rehabilitation and metabolic regulation, highlighting their therapeutic potential in neurological and cardiac rehabilitation as well as in the management of metabolic syndrome, while emphasizing the biological properties and functional roles of the most extensively studied myokines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Recent research on exercise has introduced a new biological dimension by demonstrating that skeletal muscle functions not only as a mechanical structure but also as an endocrine organ.
📊
Key Findings & Data:Myokines released from skeletal muscle during exercise play critical roles in metabolic regulation, inflammation control, nervous system function, and tissue regeneration.
💡
Conclusion & Impact:This review examines the effects of exercise-induced myokines on clinical rehabilitation and metabolic regulation, highlighting their therapeutic potential in neurological and cardiac rehabilitation as well as in the management of metabolic syndrome, while emphasizing the biological properties and functional roles of the most extensively studied myokines.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Exercise · metabolism · myokines

Abstract

Recent research on exercise has introduced a new biological dimension by demonstrating that skeletal muscle functions not only as a mechanical structure but also as an endocrine organ. Myokines released from skeletal muscle during exercise play critical roles in metabolic regulation, inflammation control, nervous system function, and tissue regeneration. Consequently, growing research interest has focused on elucidating the biological and therapeutic significance of myokines. This review examines the effects of exercise-induced myokines on clinical rehabilitation and metabolic regulation, highlighting their therapeutic potential in neurological and cardiac rehabilitation as well as in the management of metabolic syndrome, while emphasizing the biological properties and functional roles of the most extensively studied myokines.

🔖

Cite This Article

Öztürk, E. Z., Alataş, M. (2026). Effects of exercise-induced myokines on rehabilitation and metabolic regulation. Journal of Health Sciences and Medicine, Volume: 9 Issue: 3. https://doi.org/10.32322/jhsm.1883007

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (63)

  1. Barbalho SM, Flato UAP, Tofano RJ, et al. Physical exercise and myokines: relationships with sarcopenia and cardiovascular complications. Int J Mol Sci. 2020;21(10):3607. doi:10.3390/ijms21103607
  2. Qi C, Song X, Wang H, Yan Y, Liu B. The role of exercise-induced myokines in promoting angiogenesis. Front Physiol. 2022;13:981577. doi:10.3389/fphys.2022.981577
  3. Severinsen MCK, Pedersen BK. Muscle–organ crosstalk: the emerging roles of myokines. Endocr Rev. 2020;41(4):594-609. doi:10.1210/endrev/bnaa016
  4. Iglesias P. Muscle in endocrinology: from skeletal muscle hormone regulation to myokine secretion and its implications in endocrine-metabolic diseases. J Clin Med. 2025;14(13):4490. doi:10.3390/jcm1413 4490
  5. Zhu M, Chen W, Zhang J. Aerobic exercise, an effective intervention for cognitive impairment after ischemic stroke. Front Aging Neurosci. 2025; 17:1514271. doi:10.3389/fnagi.2025.1514271
  6. De Assis GG, Murawska-Ciałowicz E. Brain-derived neurotrophic factor and stroke: perspectives on exercise as a health care strategy. Hum Mov. 2024;25(1):1-14. doi:10.5114/hm.2024.136050
  7. Jodeiri Farshbaf M, Alviña K. Multiple roles in neuroprotection for the exercise-derived myokine irisin. Front Aging Neurosci. 2021;13:649929. doi:10.3389/fnagi.2021.649929
  8. Villamil-Parra W, Moscoso-Loaiza L. Effects of physical exercise on irisin and BDNF concentrations, and their relationship with cardiometabolic and mental health of individuals with metabolic syndrome: a systematic review. Exp Gerontol. 2024;198:112640. doi:10.1016/j.exger.2024.112640
  9. Montero-Almagro G, Bernal-Utrera C, Geribaldi-Doldán N, Nunez-Abades P, Castro C, Rodriguez-Blanco C. Influence of high-intensity interval training on neuroplasticity markers in post-stroke patients: systematic review. J Clin Med. 2024;13(7):1985. doi:10.3390/jcm13071985
  10. Grześkiewicz M, Kobak JE, Drewniak H, Terlecki P, Przywara S. Irisin-the future of ischemic stroke therapy? Acta Angiol. 2023;29(1):19-24. doi:10.5603/AA.2023.0006
  11. Xiao W, Yang Y, Bai L, et al. Exercise-induced irisin ameliorates cognitive impairment following chronic cerebral hypoperfusion by suppressing neuroinflammation and hippocampal neuronal apoptosis. J Neuroinflammation. 2025;22(1):168. doi:10.1186/s12974-025-03493-5
  12. Chen X, Zhang G, Liu M, He J, Zhang Z. New perspectives on molecular mechanisms underlying exercise-induced benefits in Parkinson disease. NPJ Parkinsons Dis. 2025;11(1):256. doi:10.1038/s41531-025-01113-w
  13. Yani S, Harris S, Jusuf AA, Goenarjo R, Makkiyah FA, Sabita R, Ibrahim N. Effect of high-intensity interval training on BDNF level in ischemic stroke rat model on recovery of motor function. Indones Biomed J. 2024; 16(2):152-161.
  14. Puoyan-Majd S, Parnow A, Rashno M, Heidarimoghadam R, Komaki A. Effects of pretreatment with coenzyme Q10 and high-intensity interval training on FNDC5, irisin, and BDNF levels and amyloid-beta plaque formation in hippocampus of Aβ-induced Alzheimer disease rats. CNS Neurosci Ther. 2025;31(2):e70221. doi:10.1111/cns.70221
  15. Skrypnik D, Skrypnik K, Granell JC, Woszczyk D, Suliburska J. Cardiac rehabilitation influences serum myokine levels in patients after acute coronary syndrome: the randomised CARDIO-REH study. Sci Rep. 2025;15(1):38951. doi:10.1038/s41598-025-22897-0
  16. Damay VA, Setiawan S, Lesmana R, Akbar MR, Lukito AA. Effects of moderate-intensity aerobic exercise on FSTL-1 regulation in atherosclerosis: a systematic review. Int J Angiol. 2023;32(1):1-10. doi:10. 1055/s-0042-1750184
  17. Esmaeili M, Vettukattil R. Exercise intensity and cardiac metabolic adaptations in elderly heart failure rehabilitation: a review. Int J Cardiol Cardiovasc Risk Prev. 2025;27:200525. doi:10.1016/j.ijcrp.2025.200525
  18. Yang M, Liu C, Jiang N, et al. Myostatin: a potential therapeutic target for metabolic syndrome. Front Endocrinol (Lausanne). 2023;14:1181913. doi:10.3389/fendo.2023.1181913
  19. Lenk K, Erbs S, Höllriegel R, et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol. 2012;19(3):404-411. doi:10.1177/1741826711402735
  20. Ramirez-Velez R, Gonzalez A, Garcia-Hermoso A, Amezqueta IL, Izquierdo M, Diez J. Revisiting skeletal myopathy and exercise training in heart failure: emerging role of myokines. Metabolism. 2023;138: 155348. doi:10.1016/j.metabol.2022.155348
  21. Lyu JX, Guo DD, Song YC, et al. Circulating myokines as novel biomarkers for cardiovascular diseases. Rev Cardiovasc Med. 2024;25(2): 56.
  22. Mińko A, Turoń-Skrzypińska A, Rył A, Mańkowska K, Cymbaluk-Płoska A, Rotter I. The significance of selected myokines in predicting the length of rehabilitation of patients after COVID-19 infection. Biomedicines. 2024;12(4):836. doi:10.3390/biomedicines12040836
  23. Luo C, Li L, Hou L, Shi F. Effects of tiered cardiac rehabilitation on CRP, TNF-α, and physical endurance in older adults with coronary heart disease. Open Life Sci. 2025;20(1):20221040.
  24. Pedersen BK, Fischer CP. Beneficial health effects of exercise-the role of IL-6 as a myokine. Trends Pharmacol Sci. 2007;28(4):152-156. doi:10. 1016/j.tips.2007.02.002
  25. Tero-Vescan A, Degens H, Matsakas A, et al. Exercise-induced muscle-fat crosstalk: molecular mediators and their pharmacological modulation for the maintenance of metabolic flexibility in aging. Pharmaceuticals (Basel). 2025;18(8):1222. doi:10.3390/ph18081222
  26. Leal LG, Lopes MA, Batista ML Jr. Physical exercise-induced myokines and muscle-adipose tissue crosstalk: a review of current knowledge and the implications for health and metabolic diseases. Front Physiol. 2018;9: 1307. doi:10.3389/fphys.2018.01307
  27. Shakoor H, Kizhakkayil J, Statsenko Y, Platat C. Separate and combined effects of moderate-intensity exercise training and detraining with protocatechuic acid on myokines and insulin-signaling pathways in male Wistar rats: a preclinical randomized study. Metabolites. 2025; 15(2):87. doi:10.3390/metabo15020087
  28. Rodríguez A, Becerril S, Ezquerro S, Méndez-Giménez L, Frühbeck G. Crosstalk between adipokines and myokines in fat browning. Acta Physiol (Oxf). 2017;219(2):362-381. doi:10.1111/apha.12686
  29. Villamil-Parra W, Moscoso-Loaiza L. Effects of physical exercise on irisin and BDNF in metabolic syndrome. Exp Gerontol. 2024;198:112640. doi:10.1016/j.exger.2024.112640
  30. Sanchis-Gomar F, Perez-Quilis C. The p38-PGC-1α-irisin-betatrophin axis: exploring new pathways in insulin resistance. Adipocyte. 2014;3(1): 67-68. doi:10.4161/adip.26709
  31. Kour H, Sharma H. Exercise-induced myokines: molecular mechanisms and systemic health benefits. Indian J Clin Anat Physiol. 2025;12(3):101-106.
  32. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387:83-90. doi:10.1038/387083a0
  33. Baig MH, Ahmad K, Moon JS, et al. Myostatin and its regulation: a comprehensive review of myostatin inhibiting strategies. Front Physiol. 2022;13:876078. doi:10.3389/fphys.2022.876078
  34. Rodgers BD, Ward CW. Myostatin/activin receptor ligands in muscle and the development status of attenuating drugs. Endocr Rev. 2022;43(2): 329-365. doi:10.1210/endrev/bnab030
  35. Stefanetti RJ, Voisin S, Russell A, Lamon S. Recent advances in understanding the role of FOXO3. F1000Res. 2018;7:F1000 Faculty Rev-1372. doi:10.12688/f1000research.15258.1
  36. Braun T, Gautel M. Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol. 2011;12(6):349-361. doi:10.1038/nrm3118
  37. George I, Bish LT, Kamalakkannan G, et al. Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail. 2010;12(5):444-453. doi:10.1093/eurjhf/hfq039
  38. Siff T, Parajuli P, Razzaque MS, Atfi A. Cancer-mediated muscle cachexia: etiology and clinical management. Trends Endocrinol Metab. 2021;32(6):382-402. doi:10.1016/j.tem.2021.03.007
  39. Heineke J, Auger-Messier M, Xu J, et al. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation. 2010;121(3):419-425. doi:10.1161/CIRCULATIONAHA.109.882068
  40. Han HQ, Zhou X, Mitch WE, Goldberg AL. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. Int J Biochem Cell Biol. 2013;45(10):2333-2347. doi:10.1016/j.biocel.2013.05.019
  41. McPherron AC. The ups and downs of exercise and insulin sensitivity: a role for the myokine myostatin in glucose metabolism? Acta Physiol (Oxf). 2016;217(1):6-10. doi:10.1111/apha.12635
  42. Chung HS, Choi KM. Exercise, exerkines, and sarcopenia. Diabetes Metab J. 2026;50(1):19.
  43. Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argilés JM. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab. 2009;296(1):E191-E202. doi:10.1152/ajpendo.90506.2008
  44. Kharitonenkov A, Wroblewski VJ, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology. 2007;148(2):774-781. doi:10.1210/en.2006-1168
  45. Schlein C, Talukdar S, Heine M, et al. FGF21 lowers plasma triglycerides by accelerating lipoprotein catabolism in white and brown adipose tissues. Cell Metab. 2016;23(3):441-453. doi:10.1016/j.cmet.2016.01.006
  46. Dutchak PA, Katafuchi T, Bookout AL, et al. Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell. 2012;148(3):556-567. doi:10.1016/j.cell.2011.11. 062
  47. Schreuder TC, Marsman HA, Lenicek M, et al. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2010;298(3):G440-G445. doi:10.1152/ajpgi.00322.2009
  48. Yu Y, Chen K. Peripheral immune and metabolic regulation of Aβ and Tau by exercise in Alzheimer’s disease. Front Immunol. 2025;16:1678526. doi:10.3389/fimmu.2025.1678526
  49. Szűcs G, Pipicz M, Szabó MR, Csont T, Török L, Csonka C. Effect of eccentric exercise on metabolic health in diabetes and obesity. Sports Med Open. 2023;9(1):91. doi:10.1186/s40798-023-00636-7
  50. Feng J, Wang X, Lu Y, Yu C, Wang X, Feng L. BAIBA involves in hypoxic training-induced browning of white adipose tissue in obese rats. Front Physiol. 2022;13:882151. doi:10.3389/fphys.2022.882151
  51. Jung TW, Hwang HJ, Hong HC, Yoo HJ, Baik SH, Choi KM. BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high-fat diet via an AMPK-PPARδ-dependent pathway in mice. Diabetologia. 2015;58(9):2096-2105. doi:10.1007/s00125-015-3663-z
  52. Rouholamini FS, Aminaei M, Aminizadeh S. Effect of eight weeks of endurance training and MitoQ supplementation on antioxidant capacity and the expression of sestrin-2 and AMPK in cardiac tissue of aged rats. Exp Gerontol. 2024;196:112572. doi:10.1016/j.exger.2024.112572
  53. Seo K, Ki SH, Shin SM. Sestrin2-AMPK activation protects mitochondrial function against glucose deprivation-induced cytotoxicity. Cell Signal. 2015;27(7):1533-1543. doi:10.1016/j.cellsig.2015.04.001
  54. Ho TK, Shiwen X, Abraham D, Tsui J, Baker D. Stromal cell-derived factor-1 (SDF-1)/CXCL12 as potential target of therapeutic angiogenesis in critical leg ischaemia. Cardiol Res Pract. 2012;2012:143209. doi:10. 1155/2012/143209
  55. Petit I, Jin D, Rafii S. The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007;28(7):299-307. doi:10.1016/j.it.2007.05.007
  56. Yoshida T, Delafontaine P. Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells. 2020;9(9):1970. doi:10. 3390/cells9091970
  57. Wang J, Zhu Q, Cao D, et al. Bone marrow-derived IGF-1 orchestrates maintenance and regeneration of the adult skeleton. Proc Natl Acad Sci U S A. 2023;120(1):e2203779120. doi:10.1073/pnas.2203779120
  58. Baghy K, Szakadáti H, Kovalszky I. Decorin the antifibrotic proteoglycan and its progression in therapy. Am J Physiol Cell Physiol. 2025;328(6): C1853-C1865.
  59. Dong Y, Zhong J, Dong L. The role of decorin in autoimmune and inflammatory diseases. J Immunol Res. 2022;2022:1283383. doi:10.1155/ 2022/1283383
  60. Bansal P, Kajal, Sharma S, Mazumder A. Role of BMP-7 in cardiovascular diseases: from molecular mechanisms to therapeutic horizons. Curr Drug Targets. 2025. In press.
  61. Smith C, du Toit R, Ollewagen T. Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation. Inflammopharmacology. 2023;31(5):2161-2172. doi:10. 1007/s10787-023-01279-0
  62. Aoi W, Hirano N, Lassiter DG, et al. Secreted protein acidic and rich in cysteine (SPARC) improves glucose tolerance via AMP-activated protein kinase activation. FASEB J. 2019;33(9):10551-10562. doi:10.1096/fj.201900822R
  63. Park SY, Hwang BO, Song NY. The role of myokines in cancer: crosstalk between skeletal muscle and tumor. BMB Rep. 2023;56(7):365-373. doi: 10.5483/BMBRep.2023-0099